share_log

Nexalin Technology Granted U.S. Patent #11944806: Transcranial Alternating Current Dynamic Frequency Stimulation Method for Anxiety, Depression, and Insomnia

Benzinga ·  Apr 3 00:01
Nexalin Technology Granted U.S. Patent #11944806: Transcranial Alternating Current Dynamic Frequency Stimulation Method for Anxiety, Depression, and Insomnia
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment